WuXi AppTec Co., Ltd. Stock price

Equities

603259

CNE1000031K4

Biotechnology & Medical Research

End-of-day quote Shanghai S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
47.03 CNY +0.97% Intraday chart for WuXi AppTec Co., Ltd. -5.98% -35.36%
Sales 2024 * 39.86B 5.52B Sales 2025 * 47.99B 6.65B Capitalization 133B 18.38B
Net income 2024 * 9.87B 1.37B Net income 2025 * 11.66B 1.62B EV / Sales 2024 * 3.07 x
Net cash position 2024 * 10.21B 1.41B Net cash position 2025 * 14.89B 2.06B EV / Sales 2025 * 2.46 x
P/E ratio 2024 *
13.9 x
P/E ratio 2025 *
11.8 x
Employees 41,116
Yield 2024 *
2.04%
Yield 2025 *
2.4%
Free-Float 66.64%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.97%
1 week-5.98%
Current month-13.67%
1 month-11.28%
3 months-35.97%
6 months-45.43%
Current year-35.36%
More quotes
1 week
46.12
Extreme 46.12
49.96
1 month
46.12
Extreme 46.12
60.52
Current year
45.20
Extreme 45.2
75.38
1 year
45.20
Extreme 45.2
93.56
3 years
45.20
Extreme 45.2
172.49
5 years
31.56
Extreme 31.5604
172.49
10 years
11.02
Extreme 11.0204
172.49
More quotes
Managers TitleAgeSince
Founder 54 00-11-30
Chief Executive Officer 56 00-11-30
Chief Executive Officer 55 15-11-30
Members of the board TitleAgeSince
Chief Investment Officer 61 06-12-31
Director/Board Member 50 16-03-22
Chief Executive Officer 56 00-11-30
More insiders
Date Price Change Volume
24-03-29 46.18 -1.81% 74,545,060
24-03-28 47.03 +0.97% 82,108,850
24-03-27 46.58 -1.85% 89,520,530
24-03-26 47.46 -2.94% 103,154,800
24-03-25 48.9 +2.07% 122,011,300

End-of-day quote Shanghai S.E., March 27, 2024

More quotes
WuXi AppTec Co., Ltd. specializes in providing a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical and biotech industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. Net sales break down by activity as follows: - laboratory services (60.9%): small molecules discovery services, bioanalytical services, medical devices safety testing services, comprehensive manufacturing and testing services for cell and gene therapies, etc.; - CMO and CDMO services (31.9%): development of manufacturing processes, production of advanced intermediates and active pharmaceutical ingredients, formulation development and dosage drug product manufacturing, for preclinical and clinical trials, new drug application, and commercial supply of chemical drugs, etc.; - clinical research services (7.1%): project planning, clinical operation and monitoring and managements of phase I-IV clinical trials, medical device trials, etc.; - other (0.1%). Net sales are distributed geographically as follows: China (25.1%), Asia (4.1%), the United States (53.6%), Europe (16%) and other (1.2%) .
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
30
Last Close Price
47.03 CNY
Average target price
74.98 CNY
Spread / Average Target
+59.43%
Consensus
  1. Stock
  2. Equities
  3. Stock WuXi AppTec Co., Ltd. - Shanghai S.E.